VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $297,000 | -85.6% | 11,293 | -44.4% | 0.09% | -93.3% |
| Q4 2015 | $2,063,000 | -100.0% | 20,293 | -14.7% | 1.32% | -55.4% |
| Q3 2015 | $4,244,195,000 | +75432.9% | 23,793 | -5.9% | 2.97% | -35.2% |
| Q2 2015 | $5,619,000 | +6.0% | 25,293 | -5.2% | 4.59% | +3.7% |
| Q1 2015 | $5,302,000 | +36.2% | 26,693 | -1.8% | 4.42% | +33.5% |
| Q4 2014 | $3,892,000 | +3.4% | 27,193 | -5.2% | 3.31% | -4.4% |
| Q3 2014 | $3,765,000 | -9.5% | 28,693 | -13.0% | 3.46% | -16.5% |
| Q2 2014 | $4,161,000 | -4.5% | 32,989 | -0.2% | 4.15% | +0.0% |
| Q1 2014 | $4,356,000 | -99.9% | 33,039 | -0.0% | 4.15% | +18.1% |
| Q4 2013 | $3,880,540,000 | +157006.9% | 33,054 | +15.2% | 3.51% | +15.2% |
| Q2 2013 | $2,470,000 | – | 28,693 | – | 3.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |